Riskpilot← Back to searchSign inGet full accessEyewatch AB
ABActiveOrg 5569864886Wallingatan 30Medical specialists activities · NACE 8622Est. 20141-4 employees
Revenue 2024
SEK 462K
-69% vs 2023
EBITDA margin
-16.5%
-137% vs 2023
Equity ratio
34.9%
Financial strength
Net profit 2024
SEK -81K
-150% vs 2023
| Revenue | SEK 462K | -69% |
| EBITDA | SEK -76K | -137% |
| Net profit | SEK -81K | -150% |
| Total assets | SEK 387K | -31% |
| Equity | SEK 135K | -38% |
| Employees | — | — |
Legal name
Eyewatch AB
Org number
5569864886
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
15 oktober 2014
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av ledamoten Styrelsen ska bestå av 1 styrelseledamot och 1 styrelsesuppleant.
Company purpose
Bolagets verksamhet ska bestå av ögonsjukvård, hälsoundersökningar, kosmetiska ansiktsbehandlingar, utbildning samt konsultverksamhet. Dessutom ska bolaget äga och förvalta värdepapper, fastigheter samt uthyrning i fastigheter och idka därmed förenlig verksamhet.
Address
Wallingatan 30
Email
md.soderberg@icloud.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 503 | 1 504 | 1 426 | 1 471 | 462 |
| Staff expenses | — | — | −837 | −898 | −296 |
| EBITDA | 690 | 464 | 254 | 209 | −76 |
| Depreciation & amort. | −3 | −0 | −5 | −6 | −6 |
| EBIT | 687 | 464 | 249 | 203 | −82 |
| Net financials | — | — | −2 | 1 | 1 |
| Profit before tax | 687 | 464 | 247 | 204 | −81 |
| Tax | −147 | −97 | −51 | −42 | — |
| Net profit | 540 | 367 | 196 | 162 | −81 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 962 | 808 | 722 | 564 | 387 |
| Equity | 741 | 608 | 304 | 216 | 135 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 221 | 200 | 418 | 347 | 252 |
| Total debt | 221 | 200 | 418 | 347 | 252 |
EBITDA margin
-16.5%
This company
15.8%
Market median
-204% vs market
20202024
Equity ratio
34.9%
This company
38.2%
Market median
+9% vs market
20202024
Return on equity
-60.3%
This company
18.4%
Market median
-428% vs market
20202024
Net profit margin
-17.6%
This company
8.1%
Market median
-317% vs market
20202024
Asset turnover
1.20×
This company
1.12×
Market median
+7% vs market
20202024
Debt / equity
1.87×
This company
0.62×
Market median
-202% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Eyewatch AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| My Caroline Yong Sun Kristoffersson | Deputy Board Member | 0 companies |
| Jan Eric Söderberg | Board of Directors | 0 companies |